Website stats and analysis
adsense unsafe advertisement

Cellular Medicines for Inflammatory Conditions Mesoblast is using its proprietary technology platform to develop and commercialize innovative cellular medicines to treat complex diseases in which inflammation plays a central role and are resistant to conventional standard of care. Its broad portfolio of late-stage product candidates comprises three product candidates in Phase development – remes...

unsafe advertisement
2.48 Rating by Usitestat

mesoblast.com was registered 2 decades 3 months ago. It has a alexa rank of #1,486,657 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, mesoblast.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 590
Daily Pageviews: 1,180

Estimated Valuation

Income Per Day: $ 4.00
Estimated Worth: $ 960.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 1,486,657
PageSpeed Score: 69 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

104.17.178.5

Hosted Country:

United States US

Location Latitude:

37.7757

Location Longitude:

-122.395
unsafe advertisement

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For mesoblast.com

Home - Mesoblast Ltd

- http://www.mesoblast.com/

Mesoblast is committed to bringing to market innovative cellular medicines to treat serious and life-threatening diseases with significant, unmet medical needs.


Overview - Mesoblast Ltd

- https://mesoblast.com/company/overview


Mesoblast - Wikipedia

- https://en.wikipedia.org/wiki/Mesoblast

Mesoblast Limited is an Australian-based regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease and back pain. The...


Webcasts & Presentations | Mesoblast

- http://investorsmedia.mesoblast.com/webcasts-presentations/

The Investor Relations website contains information about Mesoblast's business for stockholders, potential investors, and financial analysts.


Mesoblast - MESO - Stock Price & News | The Motley Fool

- https://www.fool.com/quote/nasdaq/mesoblast/meso/

Real time Mesoblast (MESO) stock price quote, stock graph, news & analysis.


Mesoblast Receives Complete Response Letter From the FDA ...

- https://www.tmcnet.com/usubmit/-mesoblast-receives-complete-response-letter-from-fda-biologics-/2020/10/01/9230963.htm

Oct 01, 2020 · The archived webcast will be available on the Investor page of the Company’s website www.mesoblast.com. About Mesoblast Mesoblast Limited (Nasdaq:MESO; ASX:MSB)...


Mesoblast Limited (MESO) Stock Price, News, Quote ...

- https://finance.yahoo.com/quote/MESO

Find the latest Mesoblast Limited (MESO) stock quote, history, news and other vital information to help you with your stock trading and investing.


Mesoblast surges as COVID-19 treatment shows promise

- https://www.afr.com/companies/healthcare-and-fitness/mesoblast-s-covid-19-treatment-shows-positive-signs-20200424-p54muq

Apr 24, 2020 · Mesoblast chief medical officer Fred Grossman said there is a significant need to improve the dismal survival outcomes in COVID-19 patients who progress to ARDS...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://markets.businessinsider.com/news/stocks/mesoblast-receives-complete-response-letter-from-the-fda-for-biologics-license-application-for-steroid-refractory-acute-graft-versus-host-disease-in-children-1029642425

Oct 02, 2020 · The archived webcast will be available on the Investor page of the Company’s website www.mesoblast.com About Mesoblast Mesoblast Limited (Nasdaq:MESO; ASX:MSB) is...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://markets.businessinsider.com/news/stocks/mesoblast-receives-complete-response-letter-from-the-fda-for-biologics-license-application-for-steroid-refractory-acute-graft-versus-host-disease-in-children-1029642425

The archived webcast will be available on the Investor page of the Company’s website www.mesoblast.com About Mesoblast Mesoblast Limited (Nasdaq:MESO; ASX:MSB) is a world leader...


Mesoblast Limited | LinkedIn

- https://www.linkedin.com/company/mesoblast

Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant,...


Mesoblast | Edison

- https://www.edisongroup.com/company/mesoblast/1619/

Oct 29, 2020 · Mesoblast is an Australia-based biotechnology company developing adult stem-cell therapies based on its proprietary MPC and MSC platforms. Its lead programs are...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://www.benzinga.com/pressreleases/20/10/g17748293/mesoblast-receives-complete-response-letter-from-the-fda-for-biologics-license-application-for-ste

E:[email protected]: Kristen Bothwell T: +1 917 613 5434 E:[email protected] Investors Schond Greenway T: +212 880 2060 E: [email protected]: Paul...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://finance.yahoo.com/news/mesoblast-receives-complete-response-letter-232500557.html

E:[email protected]. Kristen Bothwell T: +1 917 613 5434 E:[email protected]. Investors Schond Greenway T: +212 880 2060 E: [email protected]. Paul...


Mesoblast Ltd ADR (MESO) Quote | Morningstar

- https://www.morningstar.com/stocks/XNAS/MESO/quote

Business Description. Mesoblast is a small cap biotech company with listings on both the ASX and the Nasdaq. The company has acquired the rights to develop and commercialize...


Mesoblast Provides Remestemcel-L Update and Quarterly ...

- https://markets.businessinsider.com/news/stocks/mesoblast-provides-remestemcel-l-update-and-quarterly-activity-report-1029449845

Jul 30, 2020 · E:[email protected] Kristen Bothwell T: +1 917 613 5434 E:[email protected] Investors Schond Greenway T: +212 880 2060 E:...


Mesoblast and Tasly Pharmaceutical Group Complete ...

- https://www.globenewswire.com/news-release/2018/10/12/1620435/0/en/Mesoblast-and-Tasly-Pharmaceutical-Group-Complete-Transaction-for-Strategic-Cardiovascular-Partnership-in-China.html

Oct 12, 2018 · Mesoblast has facilities in Melbourne, New York, Singapore and Texas and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO)....


Mesoblast (@Mesoblast) | Stocktwits

- https://stocktwits.com/Mesoblast

The latest messages and market ideas from Mesoblast (@Mesoblast) on Stocktwits. Mesoblast Limited (ASX:MSB; USOTC:MBLTY) is developing novel biotherapeutics derived from its...


Mesoblast Receives Ethics Approval to Treat COVID-19 ...

- https://www.globenewswire.com/news-release/2020/09/02/2087511/0/en/Mesoblast-Receives-Ethics-Approval-to-Treat-COVID-19-Patients-in-Australia.html

Sep 02, 2020 · Media Julie Meldrum T: +61 3 9639 6036 E:[email protected] Kristen Bothwell T: +1 917 613 5434 E:[email protected] Investors Schond Greenway T:...


Mesoblast - Crunchbase Company Profile & Funding

- https://www.crunchbase.com/organization/mesoblast

Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed...


MESO - Mesoblast Limited • BioPharmCatalyst

- https://www.biopharmcatalyst.com/company/meso

The archived webcast will be available on the Investor page of the Company's website www.mesoblast.com About Mesoblast Mesoblast Limited (NASDAQ: MESO , ASX:MSB))) is a world...

Page Resources Breakdown

Homepage Links Analysis

Home - Mesoblast Ltd
Learn more about Mesoblast's adult stem cell research and the potential to cure human disease.

Website Inpage Analysis

H1 Headings: 4 H2 Headings: Not Applicable
H3 Headings: Not Applicable H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 5
Google Adsense: Not Applicable Google Analytics: UA-40783513-1

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Mon, 08 Jul 2019 04:22:13 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
X-Content-Type-Options: nosniff
X-Powered-By: PHP/7.2.15
Expires: Wed, 17 Aug 2005 00:00:00 GMT
Last-Modified: Mon, 08 Jul 2019 04:23:19 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Server: cloudflare
CF-RAY: 4f2f469bce187cd0-MUC
Content-Encoding: gzip

Domain Information

Domain Registrar: TPP Domains Pty Ltd. dba TPP Internet
Registration Date: 2004-08-11 2 decades 3 months 2 days ago
Last Modified: 2018-06-25 6 years 4 months 3 weeks ago

DNS Record Analysis

Host Type TTL Extra
mesoblast.com A 287 IP: 104.17.178.5
mesoblast.com A 287 IP: 104.17.177.5
mesoblast.com NS 86400 Target: josh.ns.cloudflare.com
mesoblast.com NS 86400 Target: mona.ns.cloudflare.com
mesoblast.com SOA 3600 MNAME: josh.ns.cloudflare.com
RNAME: dns.cloudflare.com
Serial: 2031166946
Refresh: 10000
Retry: 2400
Expire: 604800
mesoblast.com MX 300 Priority: 10
Target: mx1-us1.ppe-hosted.com
mesoblast.com MX 300 Priority: 20
Target: mx2-us1.ppe-hosted.com
mesoblast.com TXT 300 TXT:
yXyh9JEPhZwSoRGdEaBgONVwQFDjfSnQKX9ns/nx
Fk6T3D1rUVStLnsoO1F68NfI4QTMcNCDOG7xENPg
yw7IQQ==
mesoblast.com TXT 300 TXT: ppe-5b0284deda2556fcb49c
mesoblast.com TXT 300 TXT: v=spf1 +a +mx +ip4:43.245.71.6
+ip4:27.131.109.2 +ip4:27.131.109.3
+ip4:168.75.166.211
a:dispatch-us.ppe-hosted.com
include:spf.protection.outlook.com ~all
mesoblast.com TXT 300 TXT:
MS=60910A88353E0DC5F166F195995A543F8A51A
929
mesoblast.com TXT 300 TXT: MS=ms54571174
mesoblast.com AAAA 287 IPV6: 2606:4700::6811:b205
mesoblast.com AAAA 287 IPV6: 2606:4700::6811:b105

Full WHOIS Lookup

Domain Name: MESOBLAST.COM
Registry Domain ID:
126953624_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.tppinternet.com
Registrar URL:
http://www.melbourneit.com.au
Updated Date:
2018-06-25T01:38:12Z
Creation Date:
2004-08-11T04:39:28Z
Registry Expiry Date:
2019-08-11T04:39:28Z
Registrar: TPP Domains Pty Ltd. dba TPP
Internet
Registrar IANA ID: 972
Registrar Abuse Contact
Email:
Registrar Abuse Contact Phone:
Domain Status: ok
https://icann.org/epp#ok
Name Server:
JOSH.NS.CLOUDFLARE.COM
Name Server:
MONA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-07-08T04:22:17Z

Similarly Ranked Websites

RockPeaks | Music Video Community

- rockpeaks.com

The open database of music video, film and television. Browse and stream clips, match personal media, contribute missing metadata.

1,486,670   $ 960.00

Optima Sonoran Village | Apartments in Scottsdale, AZ

- optimasonoranvillage.com

Check for available units at Optima Sonoran Village in Scottsdale, AZ. View floor plans, photos, and community amenities. Make Optima Sonoran Village your new home.

1,486,671   $ 960.00

リネット LINNET :Linen cotton Fabrics & mercerie Garden*Garden@LINNET...

- lin-net.com

Welcome to LINNET, Kyoto, Japan/ 京都の LINNET のトップページです。LINNET is a company introducing the original linen fabrics and products. Also we carry Linen Yarns, Buttons , Original...

1,486,672   $ 960.00

Plantar Fasciitis Resource - Plantar Fasciitis Resource

- plantarfasciitisresource.com

Plantar Fasciitis Resource

1,486,687   $ 960.00

m4n.nl | Jouw startpagina

- m4n.nl

Jouw startpagina

1,486,688   $ 960.00
unsafe advertisement